Get started
Author

Viktoriya V. Keyer

Observed names: V. Keyer, V.V. Keyer, Viktoriya Keer, Viktoriya Keyer
ORCID: 0000-0001-8885-2387
Observed ORCID: 0000-0001-8885-2387
OpenAlex ID: A5063665259
Synthesis and Antiviral Properties against SARS-CoV-2 of Epoxybenzooxocino[4,3-b]Pyridine Derivatives
2022 · Alena L. Stalinskaya, Nadezhda V. Martynenko, et al. · Molecules · 22
PDF
Tilorone and Cridanimod Protect Mice and Show Antiviral Activity in Rats despite Absence of the Interferon-Inducing Effect in Rats
2022 · Viktoriya Keyer, Laura Syzdykova, et al. · Pharmaceuticals · 9
PDF
Fluorescent tagging the NS1 protein in yellow fever virus: Replication-capable viruses which produce the secretory GFP-NS1 fusion protein
2020 · Laura R. Syzdykova, Stephan Binke, et al. · Virus Research · 9
Non‐industrial production of therapeutic lentiviral vectors: How to provide vectors to academic CAR‐T
2024 · Viktoriya Keyer, Laura Syzdykova, et al. · Biotechnology and Bioengineering · 8
PDF
Introducing CAR-T Therapy in Kazakhstan: Establishing Academic-Scale Lentiviral Vector and CAR-T Cell Production
2025 · Viktoriya Keyer, Aitolkyn Kydyrbayeva, et al. · Biomolecules · 6
PDF
Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked
2023 · Murat Zh. Zhurinov, Alfira F. Miftakhova, et al. · Molecules · 6
PDF
Process for production of chimeric antigen receptor-transducing lentivirus particles using infection with replicon particles containing self-replicating RNAs
2023 · Laura Syzdykova, Gulzat Zauatbayeva, et al. · Biochemical Engineering Journal · 4
Towards development of plasmacytoma cells-based expression systems utilizing alphavirus vectors: An NS0-VEE model
2019 · Viktoriya V. Keyer, Alexandr B. Shevtsov, et al. · Journal of Virological Methods · 3
Inhibitory Activity of Artemisia Annua L. Extracts Against Sars-cov-2 Coronavirus
2022 · M. Zhurinov, A. Miftakhova, et al. · Eurasian journal of applied biotechnology · 2
PDF
Synthetic genomics-based generation of the tick-borne encephalitis virus Siberian subtype prototype strain and E51K-attenuated variant for vaccine development and antiviral screening
2025 · Tolganay Kulatay, Elena Sedova, et al. · Virologica Sinica · 1
Application of Pseudoinfectious Viruses in Transient Gene Expression in Mammalian Cells: Combining Efficient Expression with Regulatory Compliance
2025 · Gulzat Zauatbayeva, Tolganay Kulatay, et al. · Biomolecules · 1
Addressing a Manufacturing Bottleneck in Car-t Therapy: Scalable Production of Transfection-grade Plasmid Dna for Car-t Vector Manufacturing
2026 · E. Bulatov, G. Nigmatulla, et al. · Eurasian journal of applied biotechnology
PDF
CAR-T Cell Therapy and Gut Microbiota Modulation in Multiple Sclerosis: Emerging Therapeutic Strategies and Current Limitations
2026 · Vitaly Chasov, Sabir Mukhametshin, et al. · Current Issues in Molecular Biology
Quality assessment of mononuclear cell concentrate obtained by automated leukapheresis for the production of CAR-T cell products
2026 · Madina Ospanova, Tolkyn Baltabayeva, et al. · Astana Medical Journal
Scalable Production of Transfection-Grade Plasmid DNA by Liquid–Liquid Extraction Without Chromatography: Application to CAR-T Vector Packaging
2026 · Gaziza Nigmatulla, Aitolkyn Kydyrbayeva, et al. · Bioengineering
Suspension-Adapted HEK293FT Cells Enable High-Density Transfection for Efficient Lentiviral Vector Production in CAR-T Therapy
2026 · Alexandr Shevtsov, Aitolkyn Kydyrbayeva, et al. · Bioengineering
Outpatient CAR-T therapy in adult hematologic malignancies: Systematic review of feasibility, toxicity, hospitalization, and resource use
2026 · Marat Shoranov, Ildar Fakhradiyev, et al. · Electronic Journal of General Medicine
PDF
Development of Replicon Cell Pools Bearing a Flavivirus RNA Replicon as a Source of HIV-1 Gag-Pol for Lentiviral Vector Production
2026 · Aitolkyn Kydyrbayeva, Viktoriya Keyer, et al. · Biology
A Replication-Competent Flavivirus Genome with a Stable GFP Insertion at the NS1-NS2A Junction
2026 · Pavel Tarlykov, Bakytkali Ingirbay, et al. · Biology
Preclinical Development of a Chimeric Yellow Fever / Tick-borne Encephalitis Virus as a Candidate Vaccine
2025 · T. Kulatay, E. Sedova, et al. · Eurasian journal of applied biotechnology
PDF
Advancing the Production of Viral Vectors for Car-t Cell Therapy in Kazakhstan
2023 · L.R. Syzdykova, V.V. Keyer, et al. · Eurasian journal of applied biotechnology
PDF
Isolation and Purification of Pregnancy-associated Glycoproteins
2022 · N. Yerzhanova, I. Iskakova, et al. · Eurasian journal of applied biotechnology
PDF
Nucleoside Analog Favipiravir Is a Poor Inhibitor Against the Sars-cov-2 Virus in Cell Culture, but Favipiravir Is Highly Active Against Venezuelan Equine Encephalitis Virus
2022 · G.M. Zauatbayeva, L.R. Syzdykova, et al. · Eurasian journal of applied biotechnology
PDF
Dna-launched Infectious Clone With an Artificial Intron: Influence on Virus Rescue and Growth
2019 · V.V. Keyer, L.R. Syzdykova, et al. · Eurasian journal of applied biotechnology
PDF
Recombinant Yellow Fever Virus Which Expresses Heterologous Protein During Replication
2018 · V.V. Keyer, A.B. Shevtsov, et al. · Biotechnology Theory and practice
PDF
Works count: 26
Citation count: 71
H-index: 6
I10-index: 1
Year
Topic
Type